CT-335

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCT-335
Drug Alias NameCT-335
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsBehcet Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreabilis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCreabilis Sa
Active IndicationsN/A
Inactive IndicationsBehcet Syndrome

Other Information

ATC CodeN/A
Related LinksN/A